Utah Retirement Systems Raises Position in Oak Street Health, Inc. (NYSE:OSH)

Posted by Defense World Staff on Mar 14th, 2023

Utah Retirement Systems increased its holdings in Oak Street Health, Inc. (NYSE:OSH – Get Rating) by 7.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 20,900 shares of the company’s stock after purchasing an additional 1,500 shares during the quarter. Utah Retirement Systems’ holdings in Oak Street Health were worth $512,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. Heritage Wealth Management LLC purchased a new position in Oak Street Health in the 2nd quarter worth $58,000. Captrust Financial Advisors raised its position in Oak Street Health by 114.5% in the 1st quarter. Captrust Financial Advisors now owns 2,688 shares of the company’s stock worth $72,000 after purchasing an additional 1,435 shares during the period. PNC Financial Services Group Inc. increased its position in shares of Oak Street Health by 1,496.3% in the first quarter. PNC Financial Services Group Inc. now owns 3,480 shares of the company’s stock valued at $93,000 after acquiring an additional 3,262 shares during the period. MetLife Investment Management LLC purchased a new position in shares of Oak Street Health in the first quarter valued at about $159,000. Finally, Wealthspire Advisors LLC purchased a new position in shares of Oak Street Health in the second quarter valued at about $164,000. Hedge funds and other institutional investors own 92.04% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on OSH. Raymond James cut shares of Oak Street Health from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 9th. Stifel Nicolaus cut shares of Oak Street Health from a “buy” rating to a “hold” rating in a research report on Wednesday, February 8th. SVB Leerink boosted their price objective on shares of Oak Street Health from $33.00 to $39.00 and gave the company a “market perform” rating in a research report on Wednesday, February 8th. William Blair cut shares of Oak Street Health from an “outperform” rating to a “market perform” rating in a research report on Thursday, February 9th. Finally, UBS Group decreased their price objective on shares of Oak Street Health from $28.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 6th. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $32.67.

Insider Buying and Selling

In related news, insider Geoffrey M. Price sold 400,000 shares of the business’s stock in a transaction dated Tuesday, February 7th. The shares were sold at an average price of $34.07, for a total transaction of $13,628,000.00. Following the sale, the insider now owns 3,874,863 shares of the company’s stock, valued at $132,016,582.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, COO Brian Clem sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 3rd. The shares were sold at an average price of $24.02, for a total value of $120,100.00. Following the transaction, the chief operating officer now owns 546,337 shares in the company, valued at $13,123,014.74. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Geoffrey M. Price sold 400,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 7th. The stock was sold at an average price of $34.07, for a total transaction of $13,628,000.00. Following the completion of the transaction, the insider now owns 3,874,863 shares in the company, valued at approximately $132,016,582.41. The disclosure for this sale can be found here. Insiders have sold 674,997 shares of company stock valued at $22,835,464 over the last quarter. Corporate insiders own 11.40% of the company’s stock.

Oak Street Health Price Performance

NYSE:OSH opened at $34.57 on Tuesday. Oak Street Health, Inc. has a one year low of $13.29 and a one year high of $35.65. The company’s 50-day simple moving average is $31.20 and its 200 day simple moving average is $25.56.

Oak Street Health (NYSE:OSH – Get Rating) last posted its quarterly earnings data on Tuesday, February 28th. The company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.58) by $0.02. Oak Street Health had a negative net margin of 23.57% and a negative return on equity of 1,883.59%. The business had revenue of $577.70 million for the quarter, compared to analyst estimates of $571.26 million. During the same quarter in the previous year, the firm posted ($0.62) earnings per share. Oak Street Health’s quarterly revenue was up 46.6% on a year-over-year basis. On average, equities research analysts anticipate that Oak Street Health, Inc. will post -1.58 EPS for the current year.

About Oak Street Health

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.